MedWatch

Novo Nordisk foundation gives billions back to Denmark to fund development

The Novo Nordisk Foundation’s role in Denmark is getting bigger and bigger, and in 2030, the foundation’s grants will reach a sum of DKK 10bn (USD 1.4bn). According to CEO Mads Krogsgaard Thomsen, public and private players must come together to shape society.

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH

If the Novo Nordisk Foundation wasn’t sending billions of kroner back into its home country, Denmark would lose out on a bunch of opportunities, says the foundation’s CEO, Mads Krogsgaard Thomsen.

”We’re in constant competition with Asian countries and other places, which is why we see it as our task to make sure some of the funds from our firms flow back into Denmark,” Krogsgaard Thomsen says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs